ArticleBlood cancer journal2026

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

Karan L Chohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.